244 related articles for article (PubMed ID: 11796611)
1. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.
Fujigaki S; Saito K; Takemura M; Maekawa N; Yamada Y; Wada H; Seishima M
Infect Immun; 2002 Feb; 70(2):779-86. PubMed ID: 11796611
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
[TBL] [Abstract][Full Text] [Related]
3. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.
Silva NM; Rodrigues CV; Santoro MM; Reis LF; Alvarez-Leite JI; Gazzinelli RT
Infect Immun; 2002 Feb; 70(2):859-68. PubMed ID: 11796621
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
[No Abstract] [Full Text] [Related]
6. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
[TBL] [Abstract][Full Text] [Related]
7. Role of IDO activation in anti-microbial defense in human native astrocytes.
Oberdörfer C; Adams O; MacKenzie CR; De Groot CJ; Däubener W
Adv Exp Med Biol; 2003; 527():15-26. PubMed ID: 15206712
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase.
Habara-Ohkubo A; Shirahata T; Takikawa O; Yoshida R
Infect Immun; 1993 May; 61(5):1810-3. PubMed ID: 8478070
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice.
Mahmoud ME; Fereig R; Nishikawa Y
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138019
[No Abstract] [Full Text] [Related]
10. Inducible Nitric Oxide Synthase Is a Key Host Factor for
Bando H; Lee Y; Sakaguchi N; Pradipta A; Ma JS; Tanaka S; Cai Y; Liu J; Shen J; Nishikawa Y; Sasai M; Yamamoto M
mBio; 2018 Oct; 9(5):. PubMed ID: 30301855
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase.
Hucke C; MacKenzie CR; Adjogble KD; Takikawa O; Däubener W
Infect Immun; 2004 May; 72(5):2723-30. PubMed ID: 15102781
[TBL] [Abstract][Full Text] [Related]
12. 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression.
Oh GS; Pae HO; Choi BM; Chae SC; Lee HS; Ryu DG; Chung HT
Biochem Biophys Res Commun; 2004 Aug; 320(4):1156-62. PubMed ID: 15249210
[TBL] [Abstract][Full Text] [Related]
13. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.
Taylor MW; Feng GS
FASEB J; 1991 Aug; 5(11):2516-22. PubMed ID: 1907934
[TBL] [Abstract][Full Text] [Related]
14. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.
Kang H; Remington JS; Suzuki Y
J Immunol; 2000 Mar; 164(5):2629-34. PubMed ID: 10679102
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.
Nagineni CN; Pardhasaradhi K; Martins MC; Detrick B; Hooks JJ
Infect Immun; 1996 Oct; 64(10):4188-96. PubMed ID: 8926087
[TBL] [Abstract][Full Text] [Related]
16. The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-gamma in vivo.
Burke F; Knowles RG; East N; Balkwill FR
Int J Cancer; 1995 Jan; 60(1):115-22. PubMed ID: 7814143
[TBL] [Abstract][Full Text] [Related]
17. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase.
Däubener W; Spors B; Hucke C; Adam R; Stins M; Kim KS; Schroten H
Infect Immun; 2001 Oct; 69(10):6527-31. PubMed ID: 11553600
[TBL] [Abstract][Full Text] [Related]
18. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
Oxenkrug GF
Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
20.
Bando H; Lee Y; Sakaguchi N; Pradipta A; Sakamoto R; Tanaka S; Ma JS; Sasai M; Yamamoto M
Front Cell Infect Microbiol; 2019; 9():140. PubMed ID: 31119110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
